Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

about

The pharmacogenetics of medications used in general anesthesia.Is there a role for pharmacogenetics in the dosing of fentanyl?

P2860

Q47213395-3CB763A9-F31F-40D6-8D26-13E3620A0389 Q53682973-BF014813-7297-49C3-9562-CA6162460D99

P2860

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

Item

http://www.wikidata.org/entity/Q44339058

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

@en

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

@nl

type

Item

label

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

@en

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

@nl

prefLabel

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

@en

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

@nl

P1476

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

@en

P2093

Carin C van der Rijt

http://www.w3.org/2001/XMLSchema#string

Joost L Jongen

http://www.w3.org/2001/XMLSchema#string

Maja Matic

http://www.w3.org/2001/XMLSchema#string

Maxime P Look

http://www.w3.org/2001/XMLSchema#string

Ron H Mathijssen

http://www.w3.org/2001/XMLSchema#string

Ron H van Schaik

http://www.w3.org/2001/XMLSchema#string

P2860

Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery

Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells

Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain

Genetics of pain perception, COMT and postoperative pain management in children.

Strategies to manage the adverse effects of oral morphine: an evidence-based report.

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

Opioid rotation for toxicity reduction in terminal cancer patients.

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.

Pain sensitivity and opioid analgesia: a pharmacogenomic twin study

P304

1391-1403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS-2016-0082

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Astrid W. Oosten

P577

2016-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27472837

http://www.w3.org/2001/XMLSchema#string

P921

opioid

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

about

P2860

P2860

Opioid treatment failure in cancer patients: the role of clinical and genetic factors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921